Hear from experienced litigators from both the generic and brand sides as well as in-house counsel and the Bench on best practices for litigating under the Patented Medicines (Notice of Compliance) Regulations. Our expert faculty will assist you to conduct proceedings under the Regulations efficiently and in a cost-effective manner, and will provide valuable insights on the current state of pharmaceutical and biosimilar litigation in Canada.

Register now and join your colleagues to explore this evolving area of law with this comprehensive and enlightening program!

PROGRAM CHAIRS

Geoff Mowatt, Dimock Stratton LLP
Vincent de Grandpré, Osler Hoskin Harcourt LLP

AGENDA

To view the full program agenda, please click here.